Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Zantac Recall And EU Regulatory Issues Hurt Sanofi In Q3

Nov 01 2019

• By Tom Gallen

Quarterly resluts on typewriter close up

Related Content

OTC Zantac Recall: Sanofi Heeds To Potential Ranitidine Contaminant

Oct 18 2019

France Orders On-Pack Warnings For Paracetamol Over Liver Damage Fears

Jul 10 2019

Contamination In Common OTC Antacid Adds To FDA's API Impurity Concerns

Sep 15 2019

Sanofi Offloads Two German OTC Brands, New CEO Prepares To Make Mark

Sep 04 2019

France Wants To Move Paracetamol, Ibuprofen And Aspirin Behind The Counter

Oct 04 2019

French Industry Loses Appeal Against Standardized OTC Packaging And Curb On Branding

Oct 28 2019

Sanofi Partners With Colombian Tech Firm Rappi To 'Transform' Healthcare In Latin America

Mar 25 2019

Germany’s OTC Market in 2018: Online Sees Double-Digit Growth, Bionorica’s Canephron Uno Tops New Launches

Feb 06 2019

Related Companies

Sanofi

GSK plc

Additional Topics

International Europe France Germany South America Sales & Earnings Regulation Dietary Supplements OTC Drugs Consumer

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window